ABIOMED Inc. (NASDAQ: ABMD) stock closed at 333.11 per share at the end of the most recent trading day (a -0.21% change compared to the prior day closing price) with a volume of 169.12K shares and market capitalization of 14.93B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 1536 people. ABIOMED Inc. CEO is Michael R. Minogue.

The one-year performance of ABIOMED Inc. stock is 111.07%, while year-to-date (YTD) performance is 2.75%. ABMD stock has a five-year performance of 237.94%. Its 52-week range is between 156.67 and 387.4, which gives ABMD stock a 52-week price range ratio of 75.12%

ABIOMED Inc. currently has a PE ratio of 75.10, a price-to-book (PB) ratio of 11.82, a price-to-sale (PS) ratio of 24.85, a price to cashflow ratio of 54.70, a PEG ratio of 2.32, a ROA of 14.68%, a ROC of 17.37% and a ROE of 16.70%. The company’s profit margin is 27.82%, its EBITDA margin is 30.50%, and its revenue ttm is $606.28 Million , which makes it $13.40 revenue per share.

Of the last four earnings reports from ABIOMED Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.10 for the next earnings report. ABIOMED Inc.’s next earnings report date is 29th Apr 2021.

The consensus rating of Wall Street analysts for ABIOMED Inc. is Moderate Buy (2.19), with a target price of $378, which is +14.61% compared to the current price. The earnings rating for ABIOMED Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ABIOMED Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ABIOMED Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.81, ATR14 : 15.31, CCI20 : 138.17, Chaikin Money Flow : 0.19, MACD : -5.18, Money Flow Index : 72.17, ROC : 13.22, RSI : 39.05, STOCH (14,3) : 96.08, STOCH RSI : 0.39, UO : 64.57, Williams %R : -3.92), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ABIOMED Inc. in the last 12-months were: Andrew J. Greenfield (Option Excercise at a value of $662 500), Andrew J. Greenfield (Sold 34 312 shares of value $11 104 551 ), Dorothy E. Puhy (Sold 35 000 shares of value $9 622 347 ), Martin P. Sutter (Option Excercise at a value of $239 760), Martin P. Sutter (Sold 37 500 shares of value $8 494 765 ), Paul G. Thomas (Sold 4 000 shares of value $1 213 640 )